Cytokines (IL-6, IL-8, TNF) - Early and reliable predictors of severe acute pancreatitis

被引:138
作者
Pooran, N [1 ]
Indaram, A [1 ]
Singh, P [1 ]
Bank, S [1 ]
机构
[1] Long Isl Jewish Med Ctr, Dept Gastroenterol, New Hyde Pk, NY 11040 USA
关键词
cytokines; pancreatitis; interleukin-6; interleukin-8; tumor necrosis factor;
D O I
10.1097/00004836-200309000-00013
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Severe acute pancreatitis is associated with a high mortality, especially when compared with mild acute pancreatitis. Early intervention in patients with severe acute pancreatitis has been shown to improve mortality. The value of cytokines (interleukin [IL]-6, IL-8 and tumor necrosis factor [TNF]-alpha) in diagnosing severe acute pancreatitis at an early stage was studied. Study: Thirty-six patients with acute pancreatitis were prospectively evaluated. Age-matched controls were obtained from healthy volunteers. Levels of IL-6, IL-8, and TNF-alpha were obtained within 24 hours of admission. Ranson's prognostic signs and Bank's clinical criteria were used to differentiate patients into mild and severe pancreatitis. Results: There was significant difference in IL-6 levels between controls and mild pancreatitis, controls and severe pancreatitis, and mild and severe pancreatitis. IL-8 levels were significantly different between controls and severe pancreatitis and mild and severe pancreatitis. There was no significant difference between controls and mild pancreatitis. The results for TNF-alpha were similar to the findings for IL-8. Conclusion: IL-6, IL-8, and TNF can be used independently in differentiating mild acute pancreatitis from early severe acute pancreatitis.
引用
收藏
页码:263 / 266
页数:4
相关论文
共 37 条
[1]   INTERLEUKIN-8 AND THE CHEMOKINE FAMILY [J].
BAGGIOLINI, M ;
LOETSCHER, P ;
MOSER, B .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1995, 17 (02) :103-108
[2]  
BANK S, 1983, AM J GASTROENTEROL, V78, P637
[3]   Evaluation of factors that have reduced mortality from acute pancreatitis over the past 20 years [J].
Bank, S ;
Singh, P ;
Pooran, N ;
Stark, B .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 35 (01) :50-60
[4]  
BANKS P, 1995, PANCREAS S, V6, P7
[5]   PLATELET-ACTIVATING-FACTOR - RECEPTORS AND SIGNAL-TRANSDUCTION [J].
CHAO, W ;
OLSON, MS .
BIOCHEMICAL JOURNAL, 1993, 292 :617-629
[6]  
DIGIOVINE FS, 1995, CYTOKINES IDENTIFICA, P159
[7]   ANTICYTOKINE STRATEGIES IN THE TREATMENT OF THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME [J].
DINARELLO, CA ;
GELFAND, JA ;
WOLFF, SM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (14) :1829-1835
[8]   Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147
[9]   EVIDENCE FOR DIFFERENT EFFECTS OF SOLUBLE TNF-RECEPTORS ON VARIOUS TNF MEASUREMENTS IN HUMAN BIOLOGICAL-FLUIDS [J].
ENGELBERTS, I ;
STEPHENS, S ;
FRANCOT, GJM ;
VANDERLINDEN, CJ ;
BUURMAN, WA .
LANCET, 1991, 338 (8765) :515-516
[10]   Lung injury in the microembolic model of acute pancreatitis and amelioration by Lexipafant (BB-882), a platelet-activating factor antagonist [J].
Galloway, SW ;
Kingsnorth, AN .
PANCREAS, 1996, 13 (02) :140-146